Sarepta Therapeutics, Inc. · NASDAQ:SRPT

Rothfuss Cristin had 22,025 Sarepta Therapeutics, Inc. shares withheld for tax (Form 4)

Traded Sep 4, 2026 · Filed Sep 8, 2026

On Sep 4, 2026, Rothfuss Cristin (EVP, General Counsel) had 22,025 Sarepta Therapeutics, Inc. shares withheld for tax at US$22.22 for US$489K, leaving 115,519 shares. Filed Sep 8, 2026 (Form 4).

Withheld for tax
22,025 shares
Price
US$22.22
Value
US$489K
Holding after
115,519 shares
Trading plan
No
Role
EVP, General Counsel

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 4, 2026Common StockShares withheld for tax22,025US$22.22115,519Direct

Source

View original at SEC

Related